Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis - Quiz - MDSpire

Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis

  • By

  • Mariusz Ciołkiewicz

  • Anna Kuryliszyn-Moskal

  • Ewa Jabłońska

  • Wioletta Ratajczak-Wrona

  • Jacek Janica

  • Włodzimierz Samborski

  • Piotr A. Klimiuk

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis

  • by Mariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Ewa Jabłońska, Wioletta Ratajczak-Wrona, Jacek Janica, Włodzimierz Samborski, Piotr A. Klimiuk

  • May 29, 2026

Related Content

Systemic Glucocorticoid Immunosuppression and Survival Among Immune Checkpoint Inhibitor Recipients

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra